Sterol composition and biosynthesis in Trypanosoma cruzi amastigotes.
A detailed analysis of the endogenous sterols present in the clinically relevant intracellular (amastigote) stages of Trypanosoma cruzi, is presented. The parasites were grown in cultured Vero cells in the absence or presence of different sterol biosynthesis inhibitors, including the C14alpha demethylase inhibitor ketoconazole and two inhibitors of delta24(25)-sterol methyl transferase, 20 piperidin-2-yl-5alpha-pregnan-3beta-20-R-diol (22,26-azasterol) and 24-(R,S),25-epiminolanosterol. Amastigotes were isolated and purified from their host cells and neutral lipids were extracted, separated and analyzed by chromatographic and mass spectrometric methods. Control (untreated) amastigotes contained as main endogenous sterols 24-methyl-cholesta-7-en-3beta-ol (ergosta-7-en-3beta-ol) and its 24-ethyl analog, plus smaller amounts of their precursor, ergosta-7,24(28)dien-3beta-ol; these cells also contained cholesterol (up to 80% by weight of total sterols), probably derived from host cells. Amastigotes that proliferated in the presence of 10 nM ketoconazole (minimal inhibitory concentration, MIC) for 24 h had a sharply reduced content of endogenous 4-desmethyl sterols with a concomitant accumulation of 24-methyl-dihydrolanosterol and 24-methylene-dihydrolanosterol. On the other hand, amastigotes incubated during the same period of time with the two inhibitors of 24(25)-SMT at their respective MICs (100-300 nM) accumulated large amounts of C27 sterols whose structure suggested, in the case of 22,26-azasterol, that delta14 sterol reductase was also inhibited. Ketoconazole produced a dose-dependent reduction in the incorporation of [2-(14)C]-acetate into the parasite's endogenous C4-desmethyl sterols with an IC50 of 50 nM, indistinguishable from the value reported previously for the extracellular epimastigote form. Taken together, the results showed that amastigotes have a simpler sterol biosynthetic pathway than that previously described for epimastigotes, lacking both delta5 and delta22 reductases. They also suggest that the 100-fold higher potency of antifungal azoles as antiproliferative agents against amastigotes, when compared with epimastigotes, is most probably due to a smaller pool of endogenous sterols in the intracellular parasites.
Liendo
A
A
Laboratorio de Quimica Biológica, Centro de Bioquímica y Biofisica, Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela.
Visbal
G
G
Piras
M M
MM
Piras
R
R
Urbina
J A
JA
D000818:Animals; D002522:Chlorocebus aethiops; D004083:Cholestanol / Q000031:analogs & derivatives / Q000494:pharmacology; D065607:Cytochrome P-450 Enzyme Inhibitors; D007654:Ketoconazole / Q000494:pharmacology; D007810:Lanosterol / Q000031:analogs & derivatives / Q000494:pharmacology; D008780:Methyltransferases / Q000037:antagonists & inhibitors; D010088:Oxidoreductases / Q000037:antagonists & inhibitors; D058886:Sterol 14-Demethylase; D013261:Sterols / Q000096:biosynthesis*; D014349:Trypanosoma cruzi / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D014709:Vero Cells
C103731:22,26-azasterol; D065607:Cytochrome P-450 Enzyme Inhibitors; D013261:Sterols; C059162:24,25-iminolanosterol; D007810:Lanosterol; D004083:Cholestanol; D010088:Oxidoreductases; D058886:Sterol 14-Demethylase; D008780:Methyltransferases; C022670:delta 24-sterol methyltransferase; D007654:Ketoconazole